Ocugen stock is up 34% year to date through Jan. 15. However, the clinical-stage biopharma company that specializes in the development of therapies used to treat rare and underserved eye diseases is …
More Ocugen Stock Might be up 34% in 2020 but There are Other Eye Care Plays Videos